AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31314785 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent-100% feedback
Number of subjects: 68
Study 31314785 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent-50% feedback
Number of subjects: 68
Study 31314785 — intervention group
Group type: EXPERIMENTAL
Intervention: Terminal-100% feedback
Number of subjects: 68
Study 31314785 — intervention group
Group type: EXPERIMENTAL
Intervention: Terminal-50% feedback
Number of subjects: 68
Study 30154003 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical endodontic retreatment
Number of subjects: 95
Study 30154003 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical endodontic retreatment
Number of subjects: 95
Study 26394780 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine treatment
Number of subjects: 51
Study 26394780 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 51
Study 24828081 — intervention group
Group type: EXPERIMENTAL
Intervention: Low emission zone and heavy traffic ban
Number of subjects: 0
Study 21118409 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm I (Empirical CPAP trial)
Number of subjects: 248
Study 21118409 — intervention group
Group type: COMPARATOR
Intervention: Algorithm II (Portable sleep monitoring followed by CPAP trial for 3 weeks)
Number of subjects: 248
Study 21118409 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm I
Number of subjects: 248
Study 21118409 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm II
Number of subjects: 248
Study 20632322 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 10 per cent ointment, 0.7 g applied perianally three times daily
Number of subjects: 74
Study 20632322 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 74
Study 20632322 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 10 per cent ointment
Number of subjects: 74
Study 18321839 — intervention group
Group type: EXPERIMENTAL
Intervention: Storytelling intervention
Number of subjects: 10
Study 18321839 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study 15978101 — intervention group
Group type: EXPERIMENTAL
Intervention: S18886 1 mg
Number of subjects: 30
Study 15978101 — intervention group
Group type: EXPERIMENTAL
Intervention: S18886 2.5 mg
Number of subjects: 30
Study 15978101 — intervention group
Group type: EXPERIMENTAL
Intervention: S18886 5 mg
Number of subjects: 30
Study 15978101 — intervention group
Group type: EXPERIMENTAL
Intervention: S18886 10 mg
Number of subjects: 30
Study 15978101 — intervention group
Group type: EXPERIMENTAL
Intervention: S18886 30 mg
Number of subjects: 30
Study 15978101 — intervention group
Group type: EXPERIMENTAL
Intervention: S18886
Number of subjects: 30
Study 12814908 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine-enriched beer (10 mg of thiamine)
Number of subjects: 49
Study 12814908 — intervention group
Group type: COMPARATOR
Intervention: Normal beer (0 mg of thiamine)
Number of subjects: 49
Study 10997482 — intervention group
Group type: EXPERIMENTAL
Intervention: SCE (synthetic conjugated estrogens, A) 0.3 mg, 0.625 mg, or 1.25 mg per day
Number of subjects: 120
Study 10997482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 8827796 — intervention group
Group type: EXPERIMENTAL
Intervention: Hedonic positive affect (exposure to positive dramatic excerpts)
Number of subjects: 0
Study 8827796 — intervention group
Group type: EXPERIMENTAL
Intervention: Hedonic negative affect (exposure to negative dramatic excerpts)
Number of subjects: 0
Study 8827796 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral affect (exposure to neutral dramatic excerpts)
Number of subjects: 0
Study 8827796 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no exposure to drama)
Number of subjects: 0
Study 1448777 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose epinephrine infusion
Number of subjects: 30
Study 1448777 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine infusion
Number of subjects: 30
Study 2868431 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol 80 mg
Number of subjects: 20
Study 2868431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30629183 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (250 mg intramuscular injections every 2 weeks for 22 weeks)
Number of subjects: 42
Study 30629183 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 42
Study 30629183 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 42
Study 28388981 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile type-BHI (mobile application 'Strong bone, Fit body' and group education)
Number of subjects: 82
Study 28388981 — intervention group
Group type: EXPERIMENTAL
Intervention: Group education only (experimental group II)
Number of subjects: 82
Study 28388981 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile type-BHI (experimental group I)
Number of subjects: 82
Study 28388981 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 25994591 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 30‐min bout of moderate‐intensity exercise
Number of subjects: 0
Study 25994591 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control for 30 minutes
Number of subjects: 0
Study 23170936 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/d)
Number of subjects: 0
Study 23170936 — intervention group
Group type: COMPARATOR
Intervention: Lean control
Number of subjects: 0
Study 21427372 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (200 mg/d for 5 days, followed by 100 mg on day 6 and 50 mg on day 7)
Number of subjects: 150
Study 21427372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 21427372 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 150
Study 19781053 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week training program
Number of subjects: 110
Study 19781053 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 110
Study 16391986 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (AZ) plus 0.9% sodium chloride
Number of subjects: 96
Study 16391986 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate (HCO3‐)
Number of subjects: 96
Study 15262612 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative computed tomography (CT)
Number of subjects: 20
Study 15262612 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative epiaortic ultrasound
Number of subjects: 20
Study 11158489 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care evidence delivery regarding the use and duration of antibiotics for otitis media.
Number of subjects: 0
Study 11158489 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 9164886 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal-averaged electrocardiography in patients with idiopathic dilated cardiomyopathy
Number of subjects: 278
Study 9164886 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal-averaged electrocardiography in relatives with left ventricular enlargement
Number of subjects: 278
Study 9164886 — intervention group
Group type: COMPARATOR
Intervention: Normal relatives and healthy controls
Number of subjects: 278
Study 7700064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg
Number of subjects: 20
Study 2823746 — intervention group
Group type: EXPERIMENTAL
Intervention: Halsted radical mastectomy (RM)
Number of subjects: 311
Study 2823746 — intervention group
Group type: COMPARATOR
Intervention: Modified radical mastectomy (MRM)
Number of subjects: 311
Study 2403603 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sulfamethoxazole and trimethoprim (1600/320 mg) plus loperamide hydrochloride (4 mg loading dose, then 2 mg after each loose stool)
Number of subjects: 227
Study 2403603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim (800/160 mg orally twice daily)
Number of subjects: 227
Study 2403603 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide hydrochloride (4 mg loading dose, then 2 mg after each loose stool)
Number of subjects: 227
Study 31791085 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-gauge core needle biopsy
Number of subjects: 1065
Study 31791085 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-gauge core needle biopsy without coaxial guidance
Number of subjects: 1065
Study 31791085 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-gauge core needle biopsy with coaxial guidance
Number of subjects: 1065
Study 31791085 — intervention group
Group type: COMPARATOR
Intervention: 14-gauge core needle biopsy with coaxial guidance
Number of subjects: 1065
Study 31791085 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-gauge core needle biopsy
Number of subjects: 1065
Study 30677766 — intervention group
Group type: EXPERIMENTAL
Intervention: MP-AzeFlu (137/50 μg AZE/FP per spray)
Number of subjects: 149
Study 30677766 — intervention group
Group type: COMPARATOR
Intervention: AZE (137 μg/spray)
Number of subjects: 149
Study 28287486 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg body mass)
Number of subjects: 21
Study 28287486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 25462393 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychotherapy (Solution-Focused Therapy, SFT, n=97)
Number of subjects: 326
Study 25462393 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychotherapy (Short-Term Psychodynamic Psychotherapy, SPP, n=101)
Number of subjects: 326
Study 25462393 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term psychodynamic psychotherapy (LPP, n=128)
Number of subjects: 326
Study 25462393 — intervention group
Group type: COMPARATOR
Intervention: Short-term therapies (SFT and SPP)
Number of subjects: 326
Study 23963054 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral α‐methylparatyrosine (AMPT)
Number of subjects: 25
Study 23963054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 21227545 — intervention group
Group type: EXPERIMENTAL
Intervention: Good outcome
Number of subjects: 587
Study 21227545 — intervention group
Group type: COMPARATOR
Intervention: No outcome provided
Number of subjects: 587
Study 21227545 — intervention group
Group type: EXPERIMENTAL
Intervention: Bad outcome
Number of subjects: 587
Study 21227545 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate quality scenarios
Number of subjects: 587
Study 21227545 — intervention group
Group type: EXPERIMENTAL
Intervention: Unambiguously good or bad outcomes
Number of subjects: 587
Study 19092692 — intervention group
Group type: EXPERIMENTAL
Intervention: AM trial (0645 h)
Number of subjects: 9
Study 19092692 — intervention group
Group type: COMPARATOR
Intervention: PM trial (1845 h)
Number of subjects: 9
Study 19092692 — intervention group
Group type: EXPERIMENTAL
Intervention: Both trials
Number of subjects: 9
Study 17050802 — intervention group
Group type: EXPERIMENTAL
Intervention: St John's wort
Number of subjects: 24
Study 17050802 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian ginseng
Number of subjects: 24
Study 17050802 — intervention group
Group type: COMPARATOR
Intervention: Ginkgo biloba
Number of subjects: 24
Study 17050802 — intervention group
Group type: COMPARATOR
Intervention: Ginger
Number of subjects: 24
Study 15718064 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-session education program
Number of subjects: 44
Study 15718064 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control condition)
Number of subjects: 44
Study 11881749 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 hours of bed rest
Number of subjects: 118
Study 11881749 — intervention group
Group type: COMPARATOR
Intervention: 6 hours of bed rest
Number of subjects: 118
Study 9550506 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for asymptomatic disease
Number of subjects: 463
Study 9550506 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy with coronary artery bypass surgery
Number of subjects: 463
Study 7890905 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg orally daily)
Number of subjects: 100
Study 7890905 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical to colchicine)
Number of subjects: 100
Study 7890905 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 100
Study 7890905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 3224534 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental (loading dose of 15 mg/kg over 30 min followed by constant infusion)
Number of subjects: 10
Study 29401210 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who chose paintings displayed in rooms
Number of subjects: 186
Study 29401210 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients whose paintings were randomly selected
Number of subjects: 186
Study 29401210 — intervention group
Group type: COMPARATOR
Intervention: Patients with no paintings
Number of subjects: 186
Study 27027616 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (N-AC) 70 mg kg(‐1)
Number of subjects: 28
Study 27027616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 24632280 — intervention group
Group type: EXPERIMENTAL
Intervention: FIRM-guided ablation
Number of subjects: 92
Study 24632280 — intervention group
Group type: COMPARATOR
Intervention: FIRM-blinded therapy
Number of subjects: 92
Study 23400715 — intervention group
Group type: EXPERIMENTAL
Intervention: Sifalimumab (0.3, 1.0, 3.0, or 10.0 mg/kg)
Number of subjects: 161
Study 23400715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 23400715 — intervention group
Group type: EXPERIMENTAL
Intervention: Sifalimumab
Number of subjects: 161
Study 22131734 — intervention group
Group type: EXPERIMENTAL
Intervention: Trayodashanga Kwatha with Madhu (Group A)
Number of subjects: 31
Study 22131734 — intervention group
Group type: EXPERIMENTAL
Intervention: Pradhamana Nasya with Trikatu + Triphala Churna (Group B)
Number of subjects: 31
Study 22131734 — intervention group
Group type: EXPERIMENTAL
Intervention: Pradhamana Nasya followed by oral Trayodashanga Kwatha with Madhu (Group C)
Number of subjects: 31
Study 18616969 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic drug treatment
Number of subjects: 2463
Study 16398774 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 900
Study 16398774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study 12851520 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive agents (beta-blocker, non-beta-blocker, or beta-blocker plus non-beta-blocker)
Number of subjects: 288
Study 12851520 — intervention group
Group type: COMPARATOR
Intervention: Untreated hypertensive women
Number of subjects: 288
Study 12851520 — intervention group
Group type: COMPARATOR
Intervention: Normotensive women
Number of subjects: 288
Study 11759977 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron-dexamethasone-lorazepam
Number of subjects: 30
Study 11759977 — intervention group
Group type: COMPARATOR
Intervention: metoclopramide-dexamethasone-lorazepam
Number of subjects: 30
Study 9231864 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid drug via patient-controlled analgesia (PCA) systems for 7 days or more
Number of subjects: 33
Study 9231864 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary measure for the simultaneous change in three variables
Number of subjects: 33
Study 7956549 — intervention group
Group type: EXPERIMENTAL
Intervention: PG05 0.25 mg
Number of subjects: 99
Study 7956549 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-802 0.125 mg
Number of subjects: 99
Study 7956549 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin i.v.
Number of subjects: 99
Study 3310925 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonathymulin 5 mg/day
Number of subjects: 0
Study 3310925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30987424 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 28
Study 30987424 — intervention group
Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 28
Study 28433814 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 70
Study 28433814 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 70
Study 25828385 — intervention group
Group type: EXPERIMENTAL
Intervention: INVOS (a trend monitor using two infrared wavelengths)
Number of subjects: 40
Study 25828385 — intervention group
Group type: EXPERIMENTAL
Intervention: FORE‐SIGHT (a monitor using four wavelengths of laser light to calculate absolute oxygen saturation)
Number of subjects: 40
Study 25828385 — intervention group
Group type: COMPARATOR
Intervention: Awake volunteers (control group)
Number of subjects: 40
Study 25828385 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of INVOS with FORE‐SIGHT
Number of subjects: 40
Study 23362148 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields (PEMFs) treatment
Number of subjects: 44
Study 23362148 — intervention group
Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 44
Study 21286922 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemic-hyperinsulinemic clamp (HCC)
Number of subjects: 7
Study 21286922 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 7
Study 19645142 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track group (FTG)
Number of subjects: 105
Study 19645142 — intervention group
Group type: COMPARATOR
Intervention: Non-fast track group (non-FTG)
Number of subjects: 105
Study 17348883 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard cylindrical implants
Number of subjects: 208
Study 17348883 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered implants
Number of subjects: 208
Study 17348883 — intervention group
Group type: COMPARATOR
Intervention: Both implant designs
Number of subjects: 208
Study 15513382 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial Hemoccult‐II test
Number of subjects: 61933
Study 15513382 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61933
Study 11380525 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HR dynamics
Number of subjects: 109
Study 9638698 — intervention group
Group type: EXPERIMENTAL
Intervention: Gow-Gates mandibular block with the new guiding device
Number of subjects: 40
Study 9638698 — intervention group
Group type: COMPARATOR
Intervention: Gow-Gates mandibular block without the guiding device (control group)
Number of subjects: 40
Study 7527229 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia plus epidural anesthesia
Number of subjects: 15
Study 7527229 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane anesthesia plus epidural anesthesia
Number of subjects: 15
Study 7527229 — intervention group
Group type: EXPERIMENTAL
Intervention: Both sevoflurane and isoflurane
Number of subjects: 15
Study 7527229 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane and isoflurane
Number of subjects: 15
Study 2592230 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for symptoms of minor psychiatric disorder at six weeks post partum
Number of subjects: 100
Study 5109411 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal chemotherapy with methotrexate
Number of subjects: 38
Study 5109411 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal chemotherapy with cytosine arabinoside
Number of subjects: 38
Study 5109411 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic intrathecal chemotherapy (control group)
Number of subjects: 38
Study 31740469 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-led interventions through women's self-help group federations
Number of subjects: 6638
Study 28164731 — intervention group
Group type: EXPERIMENTAL
Intervention: PEC I (consume 50 mL of PEC/day)
Number of subjects: 60
Study 28164731 — intervention group
Group type: EXPERIMENTAL
Intervention: PEC II (consume 100 mL of PEC/day)
Number of subjects: 60
Study 28164731 — intervention group
Group type: COMPARATOR
Intervention: Placebo (consume 50 mL of simulated prune drink)
Number of subjects: 60
Study 25740672 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol 5 mg/mL solution applied twice daily for an average of 4.0 ± 1.1 months
Number of subjects: 60
Study 25740672 — intervention group
Group type: COMPARATOR
Intervention: Combined sequential pulsed dye and Nd:YAG laser treatment for an average of 5.5 ± 0.9 months
Number of subjects: 60
Study 23942577 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative spiritual/religious training intervention (Zikr), 5 sessions of 45 minutes duration
Number of subjects: 70
Study 23942577 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 70
Study 21269990 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based environment
Number of subjects: 180
Study 21269990 — intervention group
Group type: COMPARATOR
Intervention: Paper-based environment
Number of subjects: 180
Study 21269990 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate literacy
Number of subjects: 180
Study 21269990 — intervention group
Group type: EXPERIMENTAL
Intervention: TOFHLA score
Number of subjects: 180
Study 21269990 — intervention group
Group type: EXPERIMENTAL
Intervention: Task environment
Number of subjects: 180
Study 19255380 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttraumatic stress disorder (PTSD)
Number of subjects: 1698
Study 19255380 — intervention group
Group type: COMPARATOR
Intervention: Exposure to traumatic events without PTSD
Number of subjects: 1698
Study 17076630 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of timolol and dorzolamide
Number of subjects: 16
Study 17076630 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost plus timolol
Number of subjects: 16
Study 15298075 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaboxadol
Number of subjects: 0
Study 11696618 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-fractionated radiotherapy (60 Gy/30 fractions/6 weeks) with concurrent cisplatin (80 mg/m² on day 1) and vindesine (3 mg/m² on days 1 and 8 every 4 weeks)
Number of subjects: 21